|
Section d2, product code - oye was entered which is a secondary code for the clearllab 10c b cell tubes, the primary code is pwd, which was not an available option for this field.There were intermittent unexpected cd19+ events appearing in the wrong place when running clearllab 10c b cell tube and clearllab 10c m2 cell tube.Specimens with questionable or abnormal scatter patterns were rerun with an alternate method.The bec field application specialist found that the issue was not occuring on all samples run and that other applications were running without issue.Troubleshooting performed by the customer and the field applications specialist indicates that there may be specimen related impact in the performance of the analysis.Per the product safety reference (prs) for clearllab reagent and clearllab 10c panels: these reagents are used as an aid in the differential diagnosis of hematologically abnormal patients having, or suspected of having, the specifically identified neoplasms.Interpretation of the results should be confirmed by a pathologist or equivalent professional in conjunction with other clinical and laboratory findings.The selected reagents are intended to evaluate the immunophenotypic profiles of various cell populations as indicated for specific medical indications in accordance with the intended use of the product.They are not intended to provide independent determination for the presence or absence of specific disease but rather provide the clinical practitioner with appropriate flow cytometric information that in combination with other modalities (cytogenetics, morphological evaluation, immunohistochemistry, molecular studies, patient history and physical examination) can be used to reach a clinical diagnosis.Labeling: per the navios instructions for use (pn: a96247ae), the user is instructed to and/or advised of: there is a risk of reporting incorrect results.Data displays used to arrive at the test result for light scatter patterns, antibody staining profiles, and all gates and boundaries should be reviewed by a laboratory professional when interpreting the data.If results are suspect, follow your laboratory's procedures to resolve.Per the clearllab instructions for use (pn: c00197): abnormal states of health are not always represented by abnormal percentages of certain leukocyte populations.An individual in an abnormal state of health may show the same leukocyte percentages as a healthy person.It is recommended to use test results in conjunction with clinical and other diagnostic data.Certain patients may present unique problems due to altered or very low numbers of certain cellular populations.Customer technical support (cts) provided replacement reagent tubes.The customer tested the new lot and found the issue was greatly improved.Bec internal identifier - (b)(4).Related event - (b)(4), mdr - 1061932-2023-00104.
|